Reps. Omar, Titus Introduce the Higher Education Marijuana Research Act
The Higher Education Marijuana Research Act addresses federal barriers limiting academic cannabis research. This legislation could accelerate evidence-based treatment protocols. It aims to bridge the gap between real-world cannabis use and clinical…
6 Things CU Boulder Research Has Taught Us About Cannabis
CU Boulder cannabis research reveals important findings that impact clinical practice and cannabis medicine. This research highlights emerging evidence clinicians should monitor closely. Understanding these insights helps guide patient care and policy…
Explore Cannabis Research Employment Opportunities in California
Cannabis research employment opportunities in California are expanding rapidly due to increased institutional investment. This growth supports workforce development essential for advancing evidence-based cannabis medicine. Job listings highlight the…
Impact of Florida Medical Cannabis Smokable Flower on THC Dispensing
Florida medical cannabis smokable flower legalization led to a sharp rise in THC dispensed per patient. This study quantifies the increase in weekly THC amounts following the 2019 policy change. Understanding these trends is crucial for clinicians and…
Psychedelic Drug Clinical Trials Update – April 2026
This update covers recent developments in psychedelic drug clinical trials relevant to cannabis clinicians. The focus is on accelerating research and patient access in 2026. These insights help clinicians navigate evolving psychoactive substance policies.
Cannabis Sales High in Michigan, but Research Barriers Persist
2026 cannabis research barriers limit clinical evidence despite high cannabis sales in Michigan. Federal restrictions create a gap impacting patient safety and treatment optimization. Clinicians face challenges advising patients without robust research…
Congress Floats Plan to Let States Opt Out of Federal Hemp THC Ban
The state hemp THC regulation opt-out plan could create varied patient access to cannabinoid products. Clinicians must understand these regulatory changes to guide patients effectively. This plan may lead to inconsistent product standards across states.
Cannabis Sales Plunge Amid Crackdown | AJP Insights
Recent cannabis sales decline enforcement has significantly impacted the medical cannabis market. Regulatory crackdowns have tightened compliance, affecting product availability. This cannabis sales decline enforcement poses challenges for patients and…
Colorado Marijuana Officials Announce Crackdown on Hemp Products Amid Risks
Colorado hemp product crackdown highlights risks from unregulated hemp products with variable cannabinoid levels and contaminants. This enforcement affects patient safety and clinical counseling. Clinicians should guide patients toward regulated cannabis…
New Bill Could Expand Access to Hemp-Derived Cannabinoid Products
The new legislation aims to expand hemp-derived cannabinoid products access by allowing states to set their own THC limits. This change could improve patient availability but complicates clinical counseling due to variable product standards. Clinicians…
